Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Novel Mouse Model Harboring Hepatitis B Virus Covalently Closed Circular DNA. | Cell Mol Gastroenterol Hepatol | 2022 | 34896285 | PubTator, text mining | PubMed |
| In situ analysis of variations of arsenicals, microbiome and transcriptome profiles along murine intestinal tract. | J Hazard Mater | 2022 | 34876320 | PubTator, text mining | PubMed |
| NTCP: a pharmacological target for multiple liver conditions. | Gut | 2022 | 34857616 | PubTator, text mining | PubMed |
| Biogenesis of hepatitis B virus e antigen is driven by translocon-associated protein complex and regulated by conserved cysteine residues within its signal peptide sequence. | FEBS J | 2022 | 34839586 | PubTator, text mining | PubMed |
| Organic Cation Transporter I and Na+ /taurocholate Co-Transporting Polypeptide are Involved in Retrorsine- and Senecionine-Induced Hepatotoxicity in HepaRG cells. | Mol Nutr Food Res | 2022 | 34826203 | PubTator, text mining | PubMed |
| Novel Bile Acid-Dependent Mechanisms of Hepatotoxicity Associated with Tyrosine Kinase Inhibitors. | J Pharmacol Exp Ther | 2022 | 34794962 | PubTator, text mining | PubMed |
| A Bayesian hierarchically structured prior for gene-based association testing with multiple traits in genome-wide association studies. | Genet Epidemiol | 2022 | 34787916 | PubTator, text mining | PubMed |
| Sodium taurocholate co-transporting polypeptide deficiency. | Clin Res Hepatol Gastroenterol | 2022 | 34757153 | PubTator, text mining | PubMed |
| The reference liver-CYP450 and UGT enzymes in healthy donor and metastatic livers: the impact of genotype. | Pharmacol Rep | 2022 | 34741761 | PubTator, text mining | PubMed |
| Ultra-long-acting (XLA) antivirals for chronic viral hepatitis. | Int J Infect Dis | 2022 | 34728344 | PubTator, text mining | PubMed |
| The enhancement role of Matrigel on HBV infection in HepG2-NTCP cells. | J Virol Methods | 2022 | 34728272 | PubTator, text mining | PubMed |
| In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model. | Hepatology | 2022 | 34687060 | PubTator, text mining | PubMed |
| Approaches to quantifying hepatitis B virus covalently closed circular DNA. | Clin Mol Hepatol | 2022 | 34674513 | PubTator, text mining | PubMed |
| Novel therapeutic targets for cholestatic and fatty liver disease. | Gut | 2022 | 34615727 | PubTator, text mining | PubMed |
| Capsid Allosteric Modulators Enhance the Innate Immune Response in Hepatitis B Virus-Infected Hepatocytes During Interferon Administration. | Hepatol Commun | 2022 | 34558845 | PubTator, text mining | PubMed |
| Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial. | Eur Radiol | 2022 | 34467453 | PubTator, text mining | PubMed |
| Towards an advanced testing strategy for genotoxicity using image-based 2D and 3D HepG2 DNA damage response fluorescent protein reporters. | Mutagenesis | 2022 | 34448005 | PubTator, text mining | PubMed |
| Diagnosis of Hepatocellular Carcinoma Using Gd-EOB-DTPA MR Imaging. | Magn Reson Med Sci | 2022 | 34421091 | PubTator, text mining | PubMed |
| Microphysiological systems in absorption, distribution, metabolism, and elimination sciences. | Clin Transl Sci | 2022 | 34378335 | PubTator, text mining | PubMed |
| Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus. | Clin Mol Hepatol | 2022 | 34281294 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=48